|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386.
2015.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Zhang Y-Z, Zhang L-H, Gao Y, Li CH, Jia
SQ, Liu N, Cheng F, Niu DY, Cho WC, Ji JF, et al: Discovery and
validation of prognostic markers in gastric cancer by genome-wide
expression profiling. World J Gastroenterol. 17:1710–1717.
2011.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Cui L, Zhang X, Ye G, Zheng T, Song H,
Deng H, Xiao B, Xia T, Yu X, Le Y, et al: Gastric juice MicroRNAs
as potential biomarkers for the screening of gastric cancer.
Cancer. 119:1618–1626. 2013.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Fang XY, Pan HF, Leng RX and Ye DQ: Long
noncoding RNAs: Novel insights into gastric cancer. Cancer Lett.
356:357–366. 2015.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Karimi P, Islami F, Anandasabapathy S,
Freedman ND and Kamangar F: Gastric cancer: Descriptive
epidemiology, risk factors, screening, and prevention. Cancer
Epidemiol Biomarkers Prev. 23:700–713. 2014.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Kim SJ, Wang YG, Lee HW, Kang HG, La SH,
Choi IJ, Irimura T, Ro JY, Bresalier RS and Chun KH: Up-regulation
of neogenin-1 increases cell proliferation and motility in gastric
cancer. Oncotarget. 5:3386–3398. 2014.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Delaunoit T: Latest developments and
emerging treatment options in the management of stomach cancer.
Cancer Manag Res. 3:257–266. 2011.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Roseweir AK, Qayyum T, Lim Z, Hammond R,
MacDonald AI, Fraser S, Oades GM, Aitchison M, Jones RJ and Edwards
J: Nuclear expression of Lyn, a Src family kinase member, is
associated with poor prognosis in renal cancer patients. BMC
Cancer. 16(229)2016.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Liu S, Hao X, Ouyang X, Dong X, Yang Y, Yu
T, Hu J and Hu L: Tyrosine kinase LYN is an oncotarget in human
cervical cancer: A quantitative proteomic based study. Oncotarget.
7:75468–75481. 2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Mao L, Deng W-W, Yu G-T, Bu LL, Liu JF, Ma
SR, Wu L, Kulkarni AB, Zhang WF and Sun ZJ: Inhibition of SRC
family kinases reduces myeloid-derived suppressor cells in head and
neck cancer. Int J Cancer. 140:1173–1185. 2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Ingley E: Functions of the Lyn tyrosine
kinase in health and disease. Cell Commun Signal.
10(21)2012.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Jin MS, Khang SK, Kim MS, Choi HS, Lee JE,
Kim KH, Jeon DG and Koh JS: Lyn expression in osteoblastic
osteosarcoma tissues and its correlation with clinicopathologic
factors. Korean J Pathol. 44:125–131. 2010.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Kim YJ, Hong S, Sung M, Park MJ, Jung K,
Noh KW, Oh DY, Lee MS, Oh E, Shin YK, et al: LYN expression
predicts the response to dasatinib in a subpopulation of lung
adenocarcinoma patients. Oncotarget. 7:82876–82888. 2016.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Aira LE, Villa E, Colosetti P, Gamas P,
Signetti L, Obba S, Proics E, Gautier F, Bailly-Maitre B, Jacquel
A, et al: The oncogenic tyrosine kinase Lyn impairs the
pro-apoptotic function of Bim. Oncogene. 37:2122–2136.
2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Mello AA, Leal MF, Rey JA, Pinto GR,
Lamarão LM, Montenegro RC, Alves AP, Assumpção PP, Borges BN, Smith
MC, et al: Deregulated expression of SRC, LYN and CKB kinases by
DNA methylation and its potential role in gastric cancer
invasiveness and metastasis. PLoS One. 10(e0140492)2015.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Patel MI, Rhoads KF, Ma Y, Ford JM, Visser
BC, Kunz PL, Fisher GA, Chang DT, Koong A, Norton JA, et al:
Seventh edition (2010) of the AJCC/UICC staging system for gastric
adenocarcinoma: Is there room for mprovement? Ann Surg Oncol.
20:1631–1638. 2013.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: a web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45:W98–W102.
2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Camp RL, Dolled-Filhart M and Rimm DL:
X-tile: A new bio-informatics tool for biomarker assessment and
outcome-based cut-point optimization. Clin Cancer Res.
10:7252–7259. 2004.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Tang J, Kong D, Cui Q, Wang K, Zhang D,
Gong Y and Wu G: Prognostic genes of breast cancer identified by
gene co-expression network analysis. Front Oncol.
8(374)2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Yi X, Yin XM and Dong Z: Inhibition of
Bid-induced apoptosis by Bcl-2. tBid insertion, Bax translocation,
and Bax/Bak oligomerization suppressed. J Biol Chem.
278:16992–16999. 2003.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Polacheck WJ, Zervantonakis IK and Kamm
RD: Tumor cell migration in complex microenvironments. Cell Mol
Life Sci. 70:1335–1356. 2013.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Zhao J, Liu Y, Zhang W, Zhou Z, Wu J, Cui
P, Zhang Y and Huang G: Long non-coding RNA Linc00152 is involved
in cell cycle arrest, apoptosis, epithelial to mesenchymal
transition, cell migration and invasion in gastric cancer. Cell
Cycle. 14:3112–3123. 2015.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Liu X, Yun F, Shi L, Li ZH, Luo NR and Jia
YF: Roles of signaling pathways in the epithelial-mesenchymal
transition in cancer. Asian Pac J Cancer Prev. 16:6201–6206.
2015.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Liu T, Sun Q, Li Q, Yang H, Zhang Y, Wang
R, Lin X, Xiao D, Yuan Y, Chen L, et al: Dual PI3K/mTOR inhibitors,
GSK2126458 and PKI-587, suppress tumor progression and increase
radiosensitivity in nasopharyngeal carcinoma. Mol Cancer Ther.
14:429–439. 2015.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Wu N, Du Z, Zhu Y, Song Y, Pang L and Chen
Z: The expression and prognostic impact of the PI3K/AKT/mTOR
signaling pathway in advanced esophageal squamous cell carcinoma.
Technol Cancer Res Treat: Jan 1, 2018 (Epub ahead of print). doi:
10.1177/1533033818758772.
|
|
27
|
Guan H, Zhou Z, Gallick GE, Jia SF,
Morales J, Sood AK, Corey SJ and Kleinerman ES: Targeting Lyn
inhibits tumor growth and metastasis in Ewing's sarcoma. Mol Cancer
Ther. 7:1807–1816. 2008.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Dong S and Byrd JC: A New role for Lyn in
the CLL microenvironment. Cancer Cell. 30:511–512. 2016.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Choi YL, Bocanegra M, Kwon MJ, Shin YK,
Nam SJ, Yang JH, Kao J, Godwin AK and Pollack JR: LYN is a mediator
of epithelial-mesenchymal transition and a target of dasatinib in
breast cancer. Cancer Res. 70:2296–2306. 2010.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Thaper D, Vahid S, Nip KM, Moskalev I,
Shan X, Frees S, Roberts ME, Ketola K, Harder KW, Gregory-Evans C,
et al: Targeting Lyn regulates Snail family shuttling and inhibits
metastasis. Oncogene. 36:3964–3975. 2017.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Liu WM, Huang P, Kar N, Burgett M,
Muller-Greven G, Nowacki AS, Distelhorst CW, Lathia JD, Rich JN,
Kappes JC, et al: Lyn facilitates glioblastoma cell survival under
conditions of nutrient deprivation by promoting autophagy. PLoS
One. 8(e70804)2013.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Nijnik A, Pistolic J, Cho P, Filewod NC,
Falsafi R, Ramin A, Harder KW and Hancock RE: The role of the Src
family kinase Lyn in the immunomodulatory activities of
cathelicidin peptide LL-37 on monocytic cells. J Leukoc Biol.
91:599–607. 2012.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Jeong SY and Seol DW: The role of
mitochondria in apoptosis. BMB Rep. 41:11–22. 2008.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Fulda S: Shifting the balance of
mitochondrial apoptosis: Therapeutic perspectives. Front Oncol.
2:121. 2012.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Franke TF, Hornik CP, Segev L, Shostak GA
and Sugimoto C: PI3K/Akt and apoptosis: Size matters. Oncogene.
22:8983–8998. 2003.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Gao N, Flynn DC, Zhang Z, Zhong XS, Walker
V, Liu KJ, Shi X and Jiang BH: G1 cell cycle progression and the
expression of G1 cyclins are regulated by PI3K/AKT/mTOR/p70S6K1
signaling in human ovarian cancer cells. Am J Physiol Cell Physiol.
287:C281–C291. 2004.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Sutton P, Borgia JA, Bonomi P and Plate
JM: Lyn, a Src family kinase, regulates activation of epidermal
growth factor receptors in lung adenocarcinoma cells. Mol Cancer.
212(76)2013.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Keck S, Freudenberg M and Huber M:
Activation of murine macrophages via TLR2 and TLR4 is negatively
regulated by a Lyn/PI3K module and promoted by SHIP1. J Immunol.
184:5809–5818. 2010.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Iqbal MS, Tsuyama N, Obata M and Ishikawa
H: A novel signaling pathway associated with Lyn, PI 3-kinase and
Akt supports the proliferation of myeloma cells. Biochem Biophys
Res Commun. 392:415–420. 2010.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Subramaniam V, Vincent IR, Gardner H, Chan
E, Dhamko H and Jothy S: CD44 regulates cell migration in human
colon cancer cells via Lyn kinase and AKT phosphorylation. Exp Mol
Pathol. 83:207–215. 2007.PubMed/NCBI View Article : Google Scholar
|
